Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.11B |
| 2 |
Vale
VALE
|
+$929M |
| 3 |
Microsoft
MSFT
|
+$877M |
| 4 |
Comcast
CMCSA
|
+$830M |
| 5 |
Mercado Libre
MELI
|
+$795M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.91B |
| 2 |
AbbVie
ABBV
|
+$1.89B |
| 3 |
Broadcom
AVGO
|
+$1.22B |
| 4 |
UnitedHealth
UNH
|
+$1.01B |
| 5 |
United Parcel Service
UPS
|
+$938M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.95% |
| 2 | Healthcare | 15.55% |
| 3 | Communication Services | 13.77% |
| 4 | Consumer Discretionary | 13.24% |
| 5 | Financials | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Gaming and Leisure Properties
GLPI
$12.5B
| $256M | 0.06% |
6,030,197
+3,064,340
| +103% | +$130M |
|
|
AZUL
227
DELISTED
Azul
AZUL
| $255M | 0.06% |
12,653,054
-15,695
| -0.1% | -$342K |
|
228
TJX Companies
TJX
$169B
| $254M | 0.06% |
3,845,386
-2,668,259
| -41% | -$179M |
|
229
Johnson & Johnson
JNJ
$629B
| $235M | 0.06% |
1,430,951
-6
| -0% | -$971 |
|
230
Centene
CNC
$33.1B
| $235M | 0.06% |
3,673,904
+405,919
| +12% | +$25.1M |
|
231
Freshpet
FRPT
$3.48B
| $234M | 0.06% |
1,470,327
-17,705
| -1% | -$2.67M |
|
232
Coursera
COUR
$1.48B
| $231M | 0.06% |
+5,721,398
| New | +$257M |
|
233
Walt Disney
DIS
$178B
| $227M | 0.06% |
+1,231,575
| New | +$227M |
|
234
Xcel Energy
XEL
$49.1B
| $224M | 0.05% |
3,375,006
+909
| +0% | +$57.5K |
|
235
British American Tobacco
BTI
$120B
| $223M | 0.05% |
5,753,959
-3,876,520
| -40% | -$146M |
|
236
Madrigal Pharmaceuticals
MDGL
$12.4B
| $221M | 0.05% |
1,893,066
+2,279
| +0.1% | +$266K |
|
|
GTM
237
ZoomInfo Technologies
GTM
$1.12B
| $220M | 0.05% |
4,507,062
+251,572
| +6% | +$12.6M |
|
238
Tesla
TSLA
$1.29T
| $219M | 0.05% |
981,459
-3
| -0% | -$753 |
|
239
RELX
RELX
$60.2B
| $218M | 0.05% |
8,677,117
+4,032
| +0% | +$100K |
|
240
Paycom
PAYC
$9.52B
| $209M | 0.05% |
563,582
-90,230
| -14% | -$35.6M |
|
241
New York Times
NYT
$10.3B
| $207M | 0.05% |
4,093,487
+275
| +0% | +$13.8K |
|
242
GSK
GSK
$101B
| $204M | 0.05% |
4,572,727
+821
| +0% | +$37.3K |
|
243
Novartis
NVS
$290B
| $202M | 0.05% |
2,365,745
+2,465
| +0.1% | +$221K |
|
244
CarMax
KMX
$8.33B
| $200M | 0.05% |
1,505,504
+100,734
| +7% | +$12.3M |
|
|
AZPN
245
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $200M | 0.05% |
1,382,982
+603,914
| +78% | +$87.2M |
|
246
Johnson Controls International
JCI
$92.6B
| $199M | 0.05% |
3,339,260
-13,148,839
| -80% | -$723M |
|
|
SRCL
247
DELISTED
Stericycle Inc
SRCL
| $198M | 0.05% |
2,937,269
+317,288
| +12% | +$21.6M |
|
248
Estee Lauder
EL
$31.7B
| $196M | 0.05% |
674,478
-1,525,232
| -69% | -$418M |
|
249
Progressive
PGR
$121B
| $192M | 0.05% |
2,005,873
+469
| +0% | +$42.6K |
|
|
PLAN
250
DELISTED
Anaplan, Inc.
PLAN
| $190M | 0.05% |
3,523,380
-676,786
| -16% | -$45.6M |
|
Similar funds
Capital Research Global Investors's Q1 2021 Portfolio in Review
As of Q1 2021, Capital Research Global Investors held 447 positions worth $409B, up 6.1% from $385B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors's Q1 2021 filing shows 43 new, 191 increased, 149 reduced and 22 closed positions. Its largest new stake was Applied Materials: 4,227,742 shares worth $565M. The largest sale was Meta Platforms (Facebook), an estimated $2.91B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Communication Services.
- Capital Research Global Investors's largest Q1 2021 buy was Applied Materials: 4,227,742 shares worth $565M.
- Capital Research Global Investors added most to JPMorgan Chase in Q1 2021, an estimated $1.11B increase.
- Capital Research Global Investors's biggest Q1 2021 reduction was Meta Platforms (Facebook), cutting an estimated $2.91B.
- Capital Research Global Investors fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $532M.
- Capital Research Global Investors's ten largest holdings make up 29% of its $409B portfolio in Q1 2021.
- Capital Research Global Investors opened 43 new positions and closed 22 in Q1 2021.
- Capital Research Global Investors's portfolio value rose 6.1% quarter-over-quarter to $409B.
Based on Capital Research Global Investors's 13F filing for Q1 2021, filed 14 May 2021.